[(2R,3R,4S,5R,6R)-3,4,5-tribenzoyloxy-6-[2-[dodecanoyl-[2-(dodecylamino)-2-oxoethyl]amino]ethoxy]oxan-2-yl]methyl benzoate | 1374977-03-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: [(2R,3R,4S,5R,6R)-3,4,5-tribenzoyloxy-6-[2-[dodecanoyl-[2-(dodecylamino)-2-oxoethyl]amino]ethoxy]oxan-2-yl]methyl benzoate
• CAS: 1374977-03-3
• 化学式: C₆₂H₈₂N₂O₁₂
• 分子量: 1047.34
• InChiKey: ZEYCZYJFTXXLBS-WCPXTWGISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  15.9
• 重原子数：
  76
• 可旋转键数：
  40
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  173
• 氢给体数：
  1
• 氢受体数：
  12

反应信息

• 作为反应物：
  描述：

  [(2R,3R,4S,5R,6R)-3,4,5-tribenzoyloxy-6-[2-[dodecanoyl-[2-(dodecylamino)-2-oxoethyl]amino]ethoxy]oxan-2-yl]methyl benzoate 在 sodium methylate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 以85%的产率得到N-[2-(dodecylamino)-2-oxoethyl]-N-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]dodecanamide
  参考文献：
  名称：

  Multicomponent Synthesis of Ugi-Type Ceramide Analogues and Neoglycolipids from Lipidic Isocyanides

  摘要：

  Unique types of ceramide and glycolipid architectures were obtained by means of Ugi reactions incorporating lipidic isocyanides as surrogates of sphingolipids. The multicomponent nature of this approach allowed for a highly efficient assembly process, wherein two of the components provided the lipidic tails while a third one incorporated either the functionality suitable for the conjugation to sugar or the sugar moiety itself. Two dissimilar strategies were implemented: (i) the initial assembly of ceramide analogues followed by glycosylation to produce a glycolipid skeleton and (ii) the one-pot construction of glycolipid frameworks by condensation of lipidic isocyanides either with lipidic amines and oligosaccharidic acids or with fatty acids and oligosaccharidic amines. Whereas both approaches are amenable for accessing analogues of anticancer glycolipids, the latter one proved to have greater potential owing to its more straightforward and efficient character. Overall, the methodology developed shows great promise toward the massive (eventually combinatorial) production of neoglycolipids suitable for biological screening.

  DOI：

  10.1021/jo300462m
• 作为产物：
  描述：

  1-异氰基十二烷 在 三氟化硼乙醚 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 6.0h， 生成 [(2R,3R,4S,5R,6R)-3,4,5-tribenzoyloxy-6-[2-[dodecanoyl-[2-(dodecylamino)-2-oxoethyl]amino]ethoxy]oxan-2-yl]methyl benzoate
  参考文献：
  名称：

  Multicomponent Synthesis of Ugi-Type Ceramide Analogues and Neoglycolipids from Lipidic Isocyanides

  摘要：

  Unique types of ceramide and glycolipid architectures were obtained by means of Ugi reactions incorporating lipidic isocyanides as surrogates of sphingolipids. The multicomponent nature of this approach allowed for a highly efficient assembly process, wherein two of the components provided the lipidic tails while a third one incorporated either the functionality suitable for the conjugation to sugar or the sugar moiety itself. Two dissimilar strategies were implemented: (i) the initial assembly of ceramide analogues followed by glycosylation to produce a glycolipid skeleton and (ii) the one-pot construction of glycolipid frameworks by condensation of lipidic isocyanides either with lipidic amines and oligosaccharidic acids or with fatty acids and oligosaccharidic amines. Whereas both approaches are amenable for accessing analogues of anticancer glycolipids, the latter one proved to have greater potential owing to its more straightforward and efficient character. Overall, the methodology developed shows great promise toward the massive (eventually combinatorial) production of neoglycolipids suitable for biological screening.

  DOI：

  10.1021/jo300462m

文献信息

• Multicomponent Synthesis of Ugi-Type Ceramide Analogues and Neoglycolipids from Lipidic Isocyanides
  作者：Karell Pérez-Labrada、Ignacio Brouard、Inmaculada Méndez、Daniel G. Rivera

  DOI：10.1021/jo300462m

  日期：2012.5.18

  Unique types of ceramide and glycolipid architectures were obtained by means of Ugi reactions incorporating lipidic isocyanides as surrogates of sphingolipids. The multicomponent nature of this approach allowed for a highly efficient assembly process, wherein two of the components provided the lipidic tails while a third one incorporated either the functionality suitable for the conjugation to sugar or the sugar moiety itself. Two dissimilar strategies were implemented: (i) the initial assembly of ceramide analogues followed by glycosylation to produce a glycolipid skeleton and (ii) the one-pot construction of glycolipid frameworks by condensation of lipidic isocyanides either with lipidic amines and oligosaccharidic acids or with fatty acids and oligosaccharidic amines. Whereas both approaches are amenable for accessing analogues of anticancer glycolipids, the latter one proved to have greater potential owing to its more straightforward and efficient character. Overall, the methodology developed shows great promise toward the massive (eventually combinatorial) production of neoglycolipids suitable for biological screening.